CSF inositol in schizophrenia and high-dose inositol treatment of schizophrenia
- 31 December 1994
- journal article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 4 (4) , 487-490
- https://doi.org/10.1016/0924-977x(94)90297-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depressionBiological Psychiatry, 1993
- Inositol treatment raises CSF inositol levelsBrain Research, 1993
- Lack of effect of inositol treatment in chronic schizophreniaBiological Psychiatry, 1993
- Inositol 6 g daily may be effective in depression but not in schizophreniaHuman Psychopharmacology: Clinical and Experimental, 1993
- Fluvoxamine improves negative symptoms in treated chronic schizophrenia: An add-on double-blind, placebo-controlled studyBiological Psychiatry, 1992
- ClozapineDrugs, 1990
- Accumulation of diacylgylcerol in platelet phosphoinositide turnover in Schizophrenia: A biological marker of good prognosis?Biological Psychiatry, 1989
- Myo-inositol transport through the blood-brain barrierNeurochemical Research, 1988
- 5-Hydroxytryptamine Receptor SubtypesAnnual Review of Neuroscience, 1988
- Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glandsBiochemical Journal, 1982